Search Browse Earnings

Aquestive Therapeutics, Inc. — SlamSEC

Aquestive Therapeutics, Inc.

Nasdaq:AQST

Pharmaceutical Preparations·WARREN, NJ

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$57.6M

+13.8% YoY

FY 2025

Adj. EBITDA

-$27.0M

-46.9% margin

FY 2025

Net Income

-$44.1M

-76.7% margin

FY 2025

EPS (Diluted)

-$0.51

FY 2025

Stock Price

$4.29

+0.7%

2026-03-09

52W Range

$2.12 – $7.55

P/E Ratio

-8.4x

Market Cap

$523.6M

Cash

$49.3M

FY 2020

Total Debt

$45.0M

FY 2025

Net Cash

$4.3M

FY 2025

Enterprise Value

$519.2M

Debt / EBITDA

0.2x

FY 2025

EV / EBITDA

-19.2x

Employees

—